The COVID-19 Pandemic – Products

Horizon Discovery has announced special commercial licensing terms to facilitate rapid access to its cGMP-compliant CHOSOURCE™ platform for the development or production of therapeutic proteins, diagnostic assay components or vaccines relating to COVID-19.

Porvair Sciences reports on increased demand for the 3D moulded intake filters and vent diffusers it supplies to GCE Healthcare, manufacturer of the Zen-O lite™ Portable Oxygen Concentrator.

Inspirata has been joined by Hamamatsu and KiKo in providing a free remote pathology initiative, available to healthcare institutions looking to provide flexibility to their staff during COVID-19

MagSi-NA Pathogens Kit from AMSBIO are designed to enable easy extraction of DNA and RNA from serum, plasma, oropharyngeal swab/nasopharyngeal swab, and any other respiratory samples for pathogen detection.

Avacta has entered into a collaboration with Cytiva to develop and manufacture a point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.

In response to the global COVID-19 pandemic, Beckman Coulter has announced that it is developing assays to identify IgM and IgG antibodies to SARS-CoV-2.

Zegami has developed a new machine learning model using x-rays of COVID-19 infected lungs, artificial intelligence techniques and data visualization tools that could help medical professionals identify coronavirus cases more effectively.

Horizon Discovery has announced the addition of an arrayed CRISPR knockout screening service for primary human B cells to its cell-based screening services.

The Promega amplification reagent has been added to the EUA list for laboratories that follow CDC’s testing protocols.

Care Access Research has announced it is leading a validation trial in conjunction with the FDA for a new at-home COVID-19 test developed by a private genomics lab that manufactures DNA screening kits.